The National Institutes of Health (NIH) is seeking suppliers for a brand name or equal reagent necessary for the amplification of DNA for next-generation sequencing in high-throughput assays for chromatin, specifically for the National Center for Advancing Translational Sciences (NCATS). The procurement aims to acquire the NEBNext Ultra II Q5 Master Mix in a bulk order of 500 mL, which is critical for optimizing protocols and facilitating high-throughput screening. This reagent is essential for advancing medical research and enhancing the development of diagnostics and therapeutics across various human diseases. Interested vendors must submit their capability statements and relevant documentation by January 22, 2025, at 9 am Eastern Time to Giuliana Faller at giuliana.faller@nih.gov.